EDC for registry studies: long-term data capture, eConsent, ePRO, and 21 CFR Part 11–aligned controls in one platform.
21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required
Registries are living programs that evolve as clinical knowledge advances, data standards change, and stakeholder needs shift. A rare disease registry launched in 2020 may need to add new genetic testing variables in 2023, incorporate a new treatment response assessment in 2025, and update its quality-of-life instrument when a revised version is published. These changes need to be implemented without disrupting existing data or breaking the continuity of long-term follow-up. Capture handles registry evolution through its configuration-driven amendment process. Registry administrators can add new CRF fields, create new forms, modify visit schedules, and update edit checks through the browser. Existing data collected under earlier versions is preserved with its original context, and the audit trail documents exactly what changed, when, and why. Participants who were enrolled under earlier versions continue their follow-up with the updated forms, while new enrollees begin with the current version. This self-service capability is essential for long-running registries, where the cumulative cost and delay of vendor-dependent modifications over years can become a significant operational burden. Registry teams need the ability to adapt their data collection independently, with the confidence that every change is documented and auditable.
Loss to follow-up is one of the most significant challenges in registry studies. Participants who were engaged at enrollment may become less responsive over years of follow-up, leading to missing data that can bias registry analyses and reduce the value of the dataset. Maintaining participant engagement over 5, 10, or 20 years requires thoughtful design of the data collection experience. ePRO plays a dual role in registry studies: it captures important patient-reported outcome data, and it serves as a regular touchpoint that keeps participants connected to the registry. When participants receive periodic questionnaires on their devices—for example, a quarterly quality-of-life assessment or a monthly symptom diary—they maintain awareness of and engagement with the registry. This regular interaction can improve retention rates compared to registries that only contact participants during annual clinic visits. Capture’s integrated ePRO supports this engagement strategy. Questionnaires are configured and scheduled within the same platform as clinician-entered data. Participants receive notifications on their devices, complete assessments at their convenience, and see that their contributions are part of an ongoing research program. Responses flow into the registry dataset with the same audit trail and quality controls as all other data.
Registry data serves multiple downstream purposes, each with its own quality requirements. Regulatory agencies may require registry data for post-marketing surveillance (e.g., FDA post-approval studies, REMS programs) or accept it as supporting evidence for label extensions. Medical device registries may be mandated by regulatory authorities to monitor long-term device performance. Publication committees use registry data for peer-reviewed manuscripts that advance clinical knowledge. And payers may use registry data to inform coverage and reimbursement decisions. For all of these uses, the credibility of registry data depends on the quality of its underlying data capture and governance. Audit trails, consent documentation, role-based access, and structured exports provide the evidence that regulators, journal reviewers, and payers need to trust the data. A registry built on a compliant platform demonstrates data integrity from enrollment through years of follow-up, which strengthens every downstream use of the data. Capture provides this foundation with 21 CFR Part 11–aligned controls, comprehensive audit trails, electronic consent records, and structured exports that support regulatory submissions, manuscript preparation, and stakeholder reporting. For registries mandated by regulatory authorities, the Enterprise tier provides validation documentation to support system qualification.
Overview
Registry studies are organized systems that collect longitudinal data on defined populations for disease surveillance, treatment outcomes, device performance, post-marketing safety, or health services research. Unlike time-limited interventional trials, registries often operate for years or even decades, continuously enrolling new participants while maintaining follow-up on existing ones. This long-duration, open-enrollment model creates specific demands on the EDC infrastructure that short-term trial-focused platforms are not designed to meet. Disease registries track natural history and treatment patterns across patient populations—for example, rare disease registries that follow patients from diagnosis through years of treatment. Product registries monitor the safety and effectiveness of drugs, biologics, or medical devices after market approval, often as a condition of regulatory approval (post-marketing commitments or REMS programs). Outcome registries track clinical outcomes across treatment approaches to inform quality improvement and comparative effectiveness research. Your EDC must support long-term follow-up with variable visit schedules, consent management that evolves over years (re-consent for protocol changes, age-of-majority transitions for pediatric registries), optional patient-reported outcomes that keep participants engaged, and complete auditability for regulatory and publication use. The system must also handle the practical challenges of multi-year operations: staff turnover at sites, evolving data standards, CRF modifications that need to be applied without disrupting existing data, and ongoing enrollment alongside active follow-up. Capture provides EDC, eConsent, ePRO, and safety in one platform with 21 CFR Part 11–aligned controls and HIPAA-aligned infrastructure. The platform supports the operational patterns unique to registries: open enrollment, variable follow-up, consent versioning, long-term data management, and structured exports for analysis and regulatory reporting. Because all data types are integrated in one system, registry teams maintain a single audit trail from enrollment through years of follow-up.
Registries present unique operational challenges that differentiate them from short-term clinical trials. The most fundamental difference is duration: a clinical trial runs for months to a few years, while a registry may operate for a decade or longer. Over this timeframe, the registry protocol may evolve (new variables added, data standards updated, follow-up schedules modified), site staff will turn over, and the technology landscape will change. Your EDC must be resilient to all of these changes while maintaining data integrity and auditability across the full life of the registry. Another critical difference is enrollment model. Clinical trials typically have defined enrollment windows and fixed sample sizes. Registries often use open or rolling enrollment, continuously adding new participants while following existing ones. This means the EDC must handle participants at different stages of follow-up simultaneously—some in their baseline visit, others in year five—without conflicts in data structures or visit definitions. Legacy EDC platforms designed for clinical trials often struggle with these registry-specific requirements. Fixed visit structures do not accommodate the variable follow-up patterns common in registries. Short-term licensing models do not fit multi-year registry operations. And systems that require vendor intervention for every CRF modification become impractical when registry protocols evolve frequently. Capture is built for study-type flexibility, including the specific patterns of registry operations. Visit schedules support fixed, variable, and event-driven follow-up. CRFs can be modified through browser-based configuration with audit trail documentation. And there are no platform limitations on study duration, so registries can operate for as long as the science requires.
FAQ
Explore the platform with a free sandbox. No sales call required.